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Message from the Editor 
One year has passed since the debut of the HKSMG Newsletter. Now we have come to the 4th issue, a little behind 
schedule though. I apologize for that because I am the editor of this issue. In this issue we have a scientific article, 
contributed by Dr. Brian Chung, on the topic of genetic and epigenetic factors of autism spectrum disorders, an 
increasingly recognized problem in Hong Kong which is also a common reason for referral to the genetic 
counselling clinic. There is also a brief report on the AGM held on 30 May. Last but not least, there is a section to 
introduce our new members. On behalf of the Society, I welcome them all. 
 
Ivan Lo 
Chairman & Editor 
 
 
 
Scientific Article 
Genetic and Epigenetic Factors Contributing to Autism Spectrum Disorders 
 
Dr. Chung Hon-Yin, Brian© 
MBBS(Hons), MRCPCH(UK), FHKAM(HK), DCH(Ireland) 
 
Clinical Assistant Professor, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong. 
 
Abstract 
Autism spectrum disorders represent a group of 
developmental disorders with strong genetic 
predisposition, including numerous monogenic 
disorders and chromosomal abnormalities. More 
recently the etiology of autism spectrum disorders has 
expanded to include genomic copy number variants and 
epigenetic factors. This article will briefly review our 
current understanding of the genetic and epigenetic 
factors contributing to autism spectrum disorders as 
well as the direction of current and future research 
studies, using a case scenario. 
 
 
Andy was a 3 y.o. boy referred for genetic evaluation because of his diagnosis of autism spectrum disorder. In 
addition there was a history of use of assisted reproductive technology (ART) prior to his conception, involving a 
cycle of ovulation stimulation, followed by in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). 
His parents wished to obtain information regarding the possibility of a connection between ART and autism. 
 
 
Autistic spectrum disorder 
 
Autism is a neuro-developmental disorder that is 
typically apparent by age 3 years. It is characterized by 
impaired communication, impaired reciprocal social 
interaction skills, and by repetitive behaviors and 
restricted interests. Autism spectrum disorder (ASD) is 
a broader umbrella term which includes autism as well 
as less severe conditions such as Asperger syndrome 
and Pervasive Developmental Disorder-not otherwise 
specified (PDD-NOS).  
 
The most recent estimate of the prevalence of autism is 
3 to 6 per 1000 when all forms of ASD are included. 
ASD occurs 4 times more commonly in males than in 
females.  
 
Assisted reproductive technology 
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Assisted reproductive technology (ART) involves 
handling eggs, sperm, or both outside the human body. 
ART includes in vitro fertilization (IVF) with or 
without intracytoplasmic sperm injection (ICSI), fresh 
or frozen/thawed embryo transfer, IVF with donor 
oocytes, and intrauterine insemination either with 
ovarian stimulation using hormonal medications such 
as clomiphene or in unstimulated cycles (IUI).  
 
Since the birth of the 1st child was born after 
conception with IVF in 1978, Over 1 million babies 
have been born after ART. At present 1-3% of children 
born in developed countries are conceived through ART 
[1].  In Canada, recent figures from 2006 showed that 
annually there were about 12,000 treatment cycles 
involving ART and at least 2974 cycles resulted in a 
live birth [2] (from the Canadian ART Registry, 
www.cfasonline.ca).   
 
Genetics of autistic spectrum disorders: what is 
known? 
 
Autism is a complex disease with a strong genetic 
component. Twin studies show a concordance of 
60-92% for monozygotic twins and 0-10% for 
dizygotic pairs, depending on phenotypic definitions 
[3-5]. Identifying the genes is not an easy task.  There 
are approximately 30,000 genes in the 23 chromosomes 
that make up the human genome.  Roughly 4,000 of 
these genes are expressed in the brain. Many genes 
have been implicated in the etiology of autism, defining 
it as an etiologically heterogeneous disorder. 
 
Despite a strong genetic load, the search for 
susceptibility genes for autism has generated mixed and 
sometimes controversial results. This could be due to 
many factors. One is that the disease may be caused by 
a combination of many common genetic variations, 
each providing a small contribution to disease 
susceptibility. Secondly, there is strong phenotypic 
heterogeneity that may confound the efforts directed at 
identifying the genetic factors involved in the disease. 
Therefore, accurate delineation of the clinical 
phenotype and demonstrating associated genetic, 
epigenetic or environmental factors contributing to 
autism becomes the major task in autism genetic 
research.  
 
From the perspective of clinical geneticists, about 10% 
are associated with a genetic syndrome (e.g. fragile X 
syndrome and tuberous sclerosis complex). Another 
5-7% are associated with a cytogenetically visible 
chromosome abnormality. And inborn errors of 
metabolism probably are found in less than 5% of 
children with ASD. Until a few years ago, the 
remaining affected individuals were presumed to have 
multi-factorial forms of ASD. More recently, 
microarray testing has shown that de novo copy number 
variations (CNVs) occur in 7-10% of ASD patients and 
that some of these children have a syndromic 
appearance. A practice guideline has been developed by 
the American College of Medical Genetics to 
recommend genetic evaluation of children with ASDs 
[6]. A template on the clinical genetic diagnostic 
evaluation of ASDs is extracted and shown in Table 1.  
 
 
Table 1. Template for the clinical genetic diagnostic evaluation of autism spectrum disorders 
Pre-evaluation 
z Confirmation of diagnosis of autism by trained professional using objective criteria and tools 
z Sensory screening (complete audiogram) 
z Electroencephalogram – if clinical suspicion of seizures 
z Cognitive testing 
z Verify results of newborn screening 
 [High-resolution chromosomal analysis and Fragile X studies may be performed before 
referral] 
First tier 
z Initial evaluation to identify known syndromes or associated conditions 
 Examination with special attention to dysmorphic features 
 Should include Woods lamp evaluation 
z If specific diagnosis is suspected, proceed with targeted testing 
 Rubella titers – if clinical indicators present 
 “Standard” metabolic screening – if clinical indicators present and if suspected condition was 
not assessed by newborn screening 
 Urine mucopolysaccharides and organic acids 
 Serum lactate, amino acids, ammonia, and acyl-carnitine profile 
z High-resolution chromosomal analysis - if not already performed 
z DNA for Fragile X – if not already performed 
Second tier 
z Fibroblast karyotype if leukocyte karyotype is normal and clonal pigmentary abnormalities are 
noted 
z Comparative genomic hybridization (chromosomal microarray)* 
z MECP2 gene testing (females only) 
z PTEN gene testing (if the head circumference is 2.5 SD greater than the mean) 
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Third tier  
z Brain magnetic resonance imaging 
z Serum and urine uric acid 
 If elevated, Hypoxanthine-guanine phosphoribosyl transferase (HgPRT) and 
Phosphoribosylpyrophosphate (PRPP) synthetase superactivity testing 
 If low, purine/pyrimidine panel (uracil excretion, xanthine, hypoxanthine) 
Extracted from Schaefer GB and Mendelsohn NJ. Genetics evaluation for the etiologic diagnosis of 
autism spectrum disorders. Genet Med 2008;10:4-12. 
*Advances in microarray technology will likely elevate aCGH to a first tier study in the near future. 
 
 
Assisted reproductive technology: Is there a link 
between ART and autism spectrum disorders? 
Current evidence 
 
With children conceived through ART now forming a 
significant subgroup of the population, there are 
concerns about lack of information about the long-term 
outcomes especially the neurodevelopmental outcome.  
 
In the joint guideline “Pregnancy Outcomes After 
Assisted Reproductive Technology” issued by the 
Society of Obstetricians and Gynaecologists of Canada 
(SOGC) and the Canadian Fertility and Andrology 
Society (CFAS) in 2006 [7], published data on the 
long-term outcome of children conceived by ART was 
evaluated. In 2- and 5-year follow-up studies, there did 
not appear to be any differences in psychomotor, 
cognitive, intellectual, or psychological development 
between IVF, IVF-ICSI, and spontaneously conceived 
children.  
 
As for Autistic spectrum disorders specifically, a recent 
systematic review [8] has summarized 8 studies 
published from 1996 to 2008. The findings were 
inconsistent and did not point to either an increased or 
decreased risk of ASD in children born following ART.  
 
Therefore in the joint SOGC-CFAS guideline, it was 
suggested that further epidemiologic and basic science 
research is needed to help determine the etiology and 
extent of the risks to children with respect to the 
long-term growth and development following ART.  
 
Recurrence of ASD in siblings/future pregnancies 
 
For individuals with known cause of autism after 
investigations, risk of recurrence is dependent on the 
specific primary diagnosis. For idiopathic autism, i.e. 
autism with no identifiable cause, the risk of recurrence 
to siblings is 4% for autism and an additional 4-6% risk 
for milder conditions, including language, social, and 
psychiatric disorders.  
 
For families with two or more affected children, the 
recurrence risk approaches 35%. Male siblings 
(brothers) of an individual with idiopathic autism have 
a 7% risk for autism and an additional 7% risk for 
milder autism spectrum disorders. Female siblings 
(sisters) of an individual with idiopathic autism have a 
1% risk for autism. The risk for a milder autism 
spectrum disorder is unknown [9]. 
There is no specific data with regards to the recurrence 
risk of autism or ASDs in siblings for children born 
with ART and diagnosed to have autism/ASDs.  
 
Epigenetics of autistic spectrum disorders: a new 
research question 
 
Epigenetics refers to modification of genetic 
information not encoded in the DNA sequence. 
Epigenetic modification can change gene expression 
patterns without a change in primary nucleotide 
sequence. Changes in gene expression often occur in 
response to epigenetic changes such as DNA 
methylation, chromatin conformation (methylation, 
acetylation), and expression of non-coding RNAs. 
Epigenetic regulation of gene expression is an 
important but poorly understood component of normal 
development and homeostasis. Disruption of normal 
epigenetic states in various genomic regions cause 
congenital malformation syndromes associated with (I) 
growth dysregulation e.g. Beckwith-Wiedemann 
syndrome (overgrowth [10]), Silver-Russell syndrome 
(intra-uterine growth retardation [11]), and (II) 
neurobehavioural features e.g. Angelman syndrome and 
Rett syndrome [12]. Further, epigenetic regulation has 
received considerable attention with the recent 
demonstration that assisted reproductive technologies 
(ART) may significantly increase the rate of 
epimutation and the incidence of Beckwith-Wiedemann 
syndrome and Angelman syndrome. 
 
Different research groups are investigating whether 
epimutations play a role in causing autism spectrum 
disorders. Current research suggests that early 
embryonic factors can change epigenetic packaging. 
One environmental factor being studied is assisted 
reproduction. The hypothesis is, assisted reproductive 
techniques (ART) such as ovulation stimulation, in 
vitro fertilization (IVF) and intracytoplasmic sperm 
injection (ICSI) may expose gametes and early 
embryos to different environmental factors that have an 
effect on epigenetic packaging. 
 
Epigenetics opens a new area of research focus in 
autism. It could provide the “missing link” between the 
genome and environmental influences on autism.  
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The 10th AGM of the Society was successfully held on 30 May 2009, following marvelous talks on the genetics of 
neurodegenerative disorders given by Prof. Larry Baum and Prof. Pak Sham, respectively. The HKSMG Book Prize 
was presented to two students from The Hong Kong Polytechnic University for their outstanding performance in the 
medical genetics course. That evening was concluded with a very nice dinner at the Dragon Place Restaurant. Here I 
sincerely thank the speakers and all the members who have attended the meeting. For those members who could not 
attend the meeting, a glimpse of the content of these talks can be obtained from the following abstracts. 
 
 
Introduction to Genetics of Brain Diseases 
 
Larry Baum 
 
School of Pharmacy, The Chinese University of Hong Kong 
 
Abstract 
Genetics contribute to different diseases to varying 
degrees. The three most important brain diseases, in 
terms of loss of the most disability adjusted life years 
(DALYs), are stroke (~5%), depression (~3%), and 
Alzheimer's (~1%). Stroke leads to 10% of deaths and 
is projected to become the single largest cause of 
mortality. Family and twin studies suggest a major 
genetic contribution to stroke: about 2/3 - 3/4. Most 
strokes are not caused by a single mutation, but 
variations in many genes, plus environmental factors, 
combine to affect stroke. Depression increases risk of 
death by suicide. About half of depression risk is 
heritable. Polymorphisms in serotonin and dopamine 
systems contribute to depression. The biggest risk 
factor for Alzheimer's disease is old age, but relatives 
of patients also display greater incidence. The 
apolipoprotein E ε4 allele is the largest genetic 
contributor. 
 
 
 
 
Report on the AGM Mini-symposium 
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Genome-Wide Association Studies and Genetic Risk Prediction in Dementia 
 
Pak C Sham, Hon-Cheong So 
 
Department of Psychiatry and Genome Research Centre, The University of Hong Kong 
 
Abstract 
Dementia affects approximately 6% of the population 
of Hong Kong above the age of 70 years, with 2/3 of 
cases being Late-Onset Alzheimer's Disease (LOAD). 
Dementia generally, and LOAD in particular, have a 
substantial genetic component in aetiology; with 
heritability estimates of 43% and 74%, respectively. 
The best established genetic susceptibility locus for 
LOAD is the APOE gene, where the ε4 allele is 
associated with increased risk (pooled OR 3.68) and the 
ε2 allele with decreased risk (pooled OR 0.64), relative 
to the ε3 allele. As for many other complex disorders, 
the genetic study of LOAD has progressed to 
systematic genome-wide association scans using 
high-throughput genotyping technologies capable to 
assaying up to 1 million single nucleotide 
polymorphisms (SNPs) and providing through linkage 
disequilibrium (LD) coverage of over 90% of all 
common single base-pair variants in the human genome. 
To date 8 genome-wide association studies (GWAS) 
have been conducted on LOAD, which have led to the 
identification of a number of novel susceptibility genes, 
although these have generally much smaller effect size 
than APOE. Even when taken together, all the 
susceptibility genes detected to date explain only a 
small proportion of the overall genetic component of 
LOAD. This has a direct bearing on the potential use of 
these known genetic variants for risk prediction of 
LOAD. 
 
 
 
Book Prize presentation 
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AGM Dinner  
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New Members 
CHAN See Ka Scarlet 
Affiliation: 
` Department of Ophthalmology, Prince of Wales Hospital, Shatin, Hong Kong  
 
CHING Kuk Lai 
Affiliation: 
` PDC Lab, Tsan Yuk Hospital, Hong Kong 
 
CHUEN Ka Yee 
Affiliation: 
` Dept of Obstetrics & Gynaecology, University of Hong Kong 
Area of interest:  
` Cytogenetics, stem cell research 
 
HE Guo-Wei 
Affiliations: 
` Research Professor of Surgery, CUHK; Senior Cardiac Surgeon, TICH Hospital, Tianjin, China; 
Director, Cardiovascular Research, St. Vincent Heart Institute, Portland, OR, USA; and Clinical 
Professor of Surgery, OHSU, USA. 
Area of interest: 
` Multivariate analysis of clinical outcome of cardiac surgery; 2. Regulation of coronary circulation 
(endothelium, nitric oxide, ion channels and molecular biology); 3. Coronary bypass grafting 
vessels – biology, pharmacology, and long-term patency; 4. Myocardial protection; 5. Genetic 
study of cardiovascular diseases (congenital, coronary, exec…) by using GWAS and other genetic 
methods. 
 
LEI Tan Monica 
Affiliation: 
` Paediatric Department, Hospital Conde S. Januário, Macau 
 
LI Martin 
Affiliation: 
` Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong 
Area of interest:  
` Genetics of autoimmune diseases and osteoporosis 
 
YANG Qin 
Affiliations: 
` Research Assistant Professor, Department of Surgery, The Chinese University of Hong Kong. 
Area of interest: 
` Regulation of coronary circulation (endothelium-smooth muscle interaction, ion channels, and 
molecular biology); 2. Myocardial protection; 3. Prenatal exposure on the development of 
cardiovascular system; 4. Genetic study of cardiovascular diseases. 
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 Scientific Activities 
 
2009 International Conference on Personalized Medicine 
Date:   19-20 September 2009 
Venue:   Auditorium and Conference Hall, Phase 2, Hong Kong Science Park 
Organizer:  Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Faculty of 
Medicine, CUHK 
Website:   www.pharmacy.cuhk.edu.hk/news/pm/php 
Enquiries:  Lawrence Lo at Tel: 26098019, Fax: 26035295, E-mail: pharmacy@cuhk.edu.hk 
